Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease.

Source:http://linkedlifedata.com/resource/pubmed/id/17670938

Proc. Natl. Acad. Sci. U.S.A. 2007 Aug 7 104 32 13192-7

Download in:

View as

Triples

General Info

PMID
17670938